AEK-0173926-6/10001/1

Eli Lilly — FEI 3010135295

Refusal Details

Date
March 18, 2026
Country
United States
Product Category
Drugs and Biologics
Product Code
61PDK74 TIRZEPATIDE (ANTI-DIABETIC)
Charges
118,3280